Medpace Holdings, Inc. Medpace Holdings, Inc.

Medpace Holdings, Inc.

MEDP

Rank in Stocks #1227
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a... Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
Share Price
$655.91
Last synced: 2026-10-21
Market Cap
$18.31B
Change (1 day)
5.38%
Change (1 year)
19.97%
Country
US
Trade Medpace Holdings, Inc. (MEDP)

Category

Healthcare
Stock price history for Medpace Holdings, Inc. (MEDP)
Highest end of day price: $615.44 on 2026-10-01

Lowest end of day price: $28.30 on 2016-08-01
Stock price history of Medpace Holdings, Inc. from 2016 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -4.71%
2025 64.84%
2024 15.73%
2023 41.41%
2022 -2.02%
2021 53.55%
2020 71.69%
2019 48.38%
2018 52.53%
2017 0.13%
2016 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$694.53 22.45%
US
$234.00 7.29%
US
$416.01 121.26%
US
$21.28 50.29%
CN
$177.93 21.98%
US